The circulating galectin-3 concentration in the serum of cancer patients has been reported to be higher than that of healthy individuals, and the level of galectin-3, which can vary across different human tumors, has been shown to correlate with tumor progression [18, 19]. This evidence concerns the gene LGALS3 and cancer.